Obesity, Lack of Physical Activity Leads to Cancer?

In a new report, researchers are noting that obesity and physical inactivity may lead to eventual breast cancer.

The study, published in the March issue of the journal Cancer Epidemiology, Biomarkers & Prevention, looked at the body mass index (BMI) and possible correlations between obese women and breast cancer. As per their results, women with the highest BMIs had a 35 percent increased chance of developing a particular type of breast cancer than those compared with the lowest BMIs. Further, they were also 39 percent more likely to develop a variety of breast cancers, they research noted.

For this analysis, researchers evaluated data from 155,723 women that were enrolled in the Women’s Health Initiative. Participants who were between the ages of 50 to 79 took part in the proceedings, and reported their exercise tendencies, weight and height. Women were then divided up into four groups ranging from the highest BMI to lowest.

Upon finishing their research, a modest link was found between a greater amount of exercise and physical activity and reduced cases of breast cancer.

While more analysis still has to be done before a definite link can be made between increased physical activity and a lesser chance of developing cancer, the connection between obesity and increased chances of developing breast cancer was made some time back.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap